Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Dec 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how effective smartwatches can be in detecting a condition called postoperative atrial fibrillation (POAF) in patients who have just undergone major thoracic surgeries, like a pneumonectomy or lobectomy. POAF happens in about 20% of these patients and can lead to serious health problems if not caught early. The trial aims to see if using a smartwatch that can monitor heart rhythms is better than standard care for identifying this condition.

To participate in the trial, you need to be an adult over 18 years old who has had major thoracic surgery within the last 48 hours and is staying in a regular surgical unit afterward. You should be able to use the smartwatch to perform a simple heart test called a single-lead ECG. However, if you have a history of atrial fibrillation or certain heart conditions, or if you're pregnant, you may not be eligible. If you join the trial, you can expect to wear the smartwatch and have your heart rhythms monitored, which could help improve care for future patients undergoing similar surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (\>18 years old).
• • Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.
• • Scheduled pneumonectomy or lobectomy.
• • Admission to a conventional surgical unit postoperatively.
• • Ability to perform single-lead ECG using a smartwatch.
• • Coverage under a social security system.
• • Signed informed consent
• Exclusion Criteria:
• • History of atrial fibrillation.
• • Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm).
• • Dependency on a pacemaker.
• • Participation in another interventional clinical trial affecting POAF incidence.
• • Mediastinal, pleural, or chest wall surgery.
• • Reoperations or surgeries performed more than 48 hours prior.
• • Pregnant women.
• • Patients under guardians or similar legal protection.